EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Effect of Vitamin D Supplementation on Cardiometabolic Outcomes in Older Australian Adults—Results from the Randomized Controlled D-Health Trial

Briony L Duarte Romero iD, Bruce K Armstrong iD, Catherine Baxter, Dallas R English iD, Peter R Ebeling iD, Gunter Hartel iD, Michael G Kimlin, Renhua Na iD, Donald S A McLeod, Hai Pham iD, Tanya Ross iD, Jolieke C van der Pols und 5 weitere

Nutrients · 2026

DOI: 10.3390/nu18020357 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2026. Verfasst von Briony L Duarte Romero und 16 weiteren Autor:innen. Beteiligte Einrichtung: Population Health Program, QIMR Berghofer, Brisbane 4006, Australia. Hauptthemen laut MEDLINE: Dietary Supplements, Vitamin D, Hypertension, Hypercholesterolemia. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, National Health and Medical Research Council project grants, Western Australian State Government in partnership with the Australian Federal Government, through Bioplatforms Australia and the National Collaborative Resear….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Observational studies have found inverse associations between 25-hydroxyvitamin D concentration and risk of hypertension, hypercholesterolemia and type 2 diabetes (T2D). More robust evidence from large-scale randomized controlled trials, however, is limited or inconclusive.

Methods

The D-Health Trial (N = 21,315) is a randomized, double-blind, placebo-controlled trial of supplementation with monthly doses of 60,000 international units of oral vitamin D3, conducted in Australians aged 60–84 years. Commencing treatment with anti-hypertensive, lipid-modifying, or anti-diabetic drugs was used as a surrogate for incident hypertension, hypercholesterolemia, and T2D, respectively. Outcomes were ascertained via linkage with the Australian Pharmaceutical Benefits Scheme database. Follow-up began 6 months after randomization; we excluded participants without linked data, and those who were prevalent cases or who died prior to start of follow-up. Flexible parametric survival models were used to estimate the effect of vitamin D supplementation on each outcome.

Results

We included 10,964 participants (vitamin D, n = 5456 [49.8%]; placebo, n = 5508 [50.2%]) in the analysis of hypertension, 12,126 participants (vitamin D, n = 6038 [49.8%]; placebo, n = 6088 [50.2%]) in the analysis of hypercholesterolemia, and 17,846 (vitamin D, n = 8931 [50.0%]; placebo, n = 8915 [50.0%]) in the analysis of T2D. Over a median follow-up of 4.6 years, 2672 (24.4%), 2554 (21.1%), and 779 (4.4%) participants developed hypertension, hypercholesterolemia, and T2D, respectively. Vitamin D supplementation had no material effect on the incidence of any of hypertension (HR 1.00; 95% CI 0.93 to 1.08), hypercholesterolemia (HR 1.05; 95% CI 0.97 to 1.13), or T2D (HR 0.97; 95% CI 0.84 to 1.12).

Conclusions

Monthly supplements of vitamin D did not alter the incidence of any of the three conditions in older, largely vitamin D-replete Australians.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dietary SupplementsVitamin DHypertensionHypercholesterolemiaDiabetes Mellitus, Type 2HumansAgedMaleFemaleAustraliaMiddle AgedDouble-Blind MethodAged, 80 and overCholecalciferol

Stichwörter der Autor:innen

diabeteshypercholesterolemiahypertensionvitamin D

Substanzen

Vitamin D25-hydroxyvitamin DCholecalciferol

Autor:innen und Institutionen

  • Population Health Program, QIMR Berghofer, Brisbane 4006, Australia.
  • School of Public Health, University of Sydney, Sydney 2050, Australia.
  • Melbourne School of Population Health, University of Melbourne, Melbourne 3053, Australia.
  • Cancer Epidemiology Division, Cancer Council Victoria, Melbourne 3002, Australia.
  • Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne 3168, Australia.
  • Griffith Institute for Biomedicine and Glycomics, Griffith University, Gold Coast 4215, Australia.

ORCID-Profile: Briony L Duarte Romero, Bruce K Armstrong, Dallas R English, Peter R Ebeling, Gunter Hartel, Renhua Na, Hai Pham, Tanya Ross, Penelope M Webb, David C Whiteman, Rachel E Neale, Mary Waterhouse

Förderung

  • National Health and Medical Research Council
  • National Health and Medical Research Council project grants
  • Western Australian State Government in partnership with the Australian Federal Government, through Bioplatforms Australia and the National Collaborative Resear…

Zitieren

APA

Duarte Romero, B. L., Armstrong, B. K., Baxter, C., English, D. R., Ebeling, P. R., Hartel, G., Kimlin, M. G., Na, R., McLeod, D. S. A., Pham, H., Ross, T., van der Pols, J. C., Venn, A. J., Webb, P. M., Whiteman, D. C., Neale, R. E., & Waterhouse, M. (2026). Effect of Vitamin D Supplementation on Cardiometabolic Outcomes in Older Australian Adults—Results from the Randomized Controlled D-Health Trial. Nutrients. https://doi.org/10.3390/nu18020357

Vancouver

Duarte Romero BL, Armstrong BK, Baxter C, English DR, Ebeling PR, Hartel G, et al. Effect of Vitamin D Supplementation on Cardiometabolic Outcomes in Older Australian Adults—Results from the Randomized Controlled D-Health Trial. Nutrients. 2026. doi:10.3390/nu18020357

BibTeX
@article{DuarteRomero2026,
  author = {Duarte Romero, Briony L and Armstrong, Bruce K and Baxter, Catherine and English, Dallas R and Ebeling, Peter R and Hartel, Gunter and Kimlin, Michael G and Na, Renhua and McLeod, Donald S A and Pham, Hai and Ross, Tanya and van der Pols, Jolieke C and Venn, Alison J and Webb, Penelope M and Whiteman, David C and Neale, Rachel E and Waterhouse, Mary},
  title = {Effect of Vitamin D Supplementation on Cardiometabolic Outcomes in Older Australian Adults—Results from the Randomized Controlled D-Health Trial},
  journal = {Nutrients},
  year = {2026},
  doi = {10.3390/nu18020357}
}
Kostenlos starten →